Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease.

Clinicians' attitude towards family planning and timing of diagnosis in autosomal dominant polycystic kidney disease. PLoS One (2017) 0.75

Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ (2007) 7.54

Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med (2014) 5.01

Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA (2011) 4.68

Sodium intake, ACE inhibition, and progression to ESRD. J Am Soc Nephrol (2011) 3.13

The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82

Dietary salt intake and mortality in patients with type 2 diabetes. Diabetes Care (2011) 2.27

The association between dietary sodium intake, ESRD, and all-cause mortality in patients with type 1 diabetes. Diabetes Care (2011) 2.16

Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers. Kidney Int (2012) 1.65

Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med (2014) 1.64

The HALT polycystic kidney disease trials: design and implementation. Clin J Am Soc Nephrol (2010) 1.59

Shared parameter models for the joint analysis of longitudinal data and event times. Stat Med (2006) 1.51

Creatinine excretion as a measure of protein nutrition in adults of varying age. JPEN J Parenter Enteral Nutr (1987) 1.44

Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int (2012) 1.24

Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2010) 1.21

Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 1.18

Analysis of baseline parameters in the HALT polycystic kidney disease trials. Kidney Int (2011) 1.13

Urine sodium excretion increased slightly among U.S. adults between 1988 and 2010. J Nutr (2014) 1.03

Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. Mayo Clin Proc (1991) 1.01

Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev (2015) 1.00

Biomarkers of meat intake and the application of nutrigenomics. Meat Sci (2009) 0.99

ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats. J Pathol (2006) 0.97

Achieving salt restriction in chronic kidney disease. Int J Nephrol (2012) 0.96

Hypertension and autosomal dominant polycystic kidney disease. Am J Kidney Dis (2011) 0.95

Dietary sodium restriction: a neglected therapeutic opportunity in chronic kidney disease. Curr Opin Nephrol Hypertens (2014) 0.94

Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease. J Renin Angiotensin Aldosterone Syst (2006) 0.89

Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease. Hypertension (2014) 0.88

Sodium chloride intake: is lower always better? J Am Soc Nephrol (2012) 0.85

Sodium intake and cardiovascular disease. Annu Rev Public Health (2011) 0.85

Demographic associations of high estimated sodium intake and frequency of consumption of high-sodium foods in people with chronic kidney disease stage 3 in England. J Ren Nutr (2014) 0.81

Benefits of and barriers to dietary sodium adherence. West J Nurs Res (2006) 0.81

Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. Kidney Int (2017) 0.78

Assessing Competencies in a Master of Science in Clinical Research Program: The Comprehensive Competency Review. Clin Transl Sci (2015) 0.75